ARTICLE | Company News
Alkermes hGH deal with Lilly
February 8, 2000 8:00 AM UTC
ALKS will use its AIR pulmonary drug delivery technology to develop an inhaled formulation of human growth hormone (hGH) for LLY. ALKS will receive upfront fees, research funding and milestones, and i...